home · filing · 0001140361-21-042603
8-K filed December 21, 2021, 6:59 PM ET
ticker ERNA
CIK 0000748592
leadership
confidence high
sentiment neutral
materiality 0.20
Director Luba Greenwood resigns from Brooklyn ImmunoTherapeutics board effective Jan 1, 2022
Ernexa Therapeutics Inc.
Luba Greenwood notified board on Dec 16, 2021, of her resignation as director effective Jan 1, 2022.
Resignation not due to any disagreement with the company’s operations, policies, or practices.
No replacement has been announced as of the filing date.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-01-01
Filed December 21, 2021, 6:59 PM ET
On December 16, 2021, Luba Greenwood notified the board of directors of her intention to resign as a director effective as of January 1, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Luba Greenwood resigned as Director at Ernexa Therapeutics Inc..
Action resigned
Role Director
Exact text from the filing
On December 16, 2021, Luba Greenwood notified the board of directors of her intention to resign as a director effective as of January 1, 2022.
View on SEC.gov
Source: SEC EDGAR
accession 0001140361-21-042603
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.